Champions Oncology, Inc.
US ˙ NasdaqCM ˙ US15870P3073

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Joel Ackerman. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Joel Ackerman har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:DVA / DaVita Inc. CFO and Treasuer 141.640
US:CSBR / Champions Oncology, Inc. Director 962.134
US:KND / Kindred Healthcare, Inc. Director 0
US:CVH / Coventry Health Care Inc Director 0
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Joel Ackerman. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb CSBR / Champions Oncology, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i CSBR / Champions Oncology, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2016-10-18 CSBR ACKERMAN JOEL 1.000 1,6977 1.000 1,6977 1.698 105 4.75 3.053 179,91
2016-10-18 CSBR ACKERMAN JOEL 201 1,6940 201 1,6940 340
2016-10-18 CSBR ACKERMAN JOEL 381 1,6900 381 1,6900 644
2016-10-18 CSBR ACKERMAN JOEL 418 1,7000 418 1,7000 711
2016-10-14 CSBR ACKERMAN JOEL 1.000 1,6581 1.000 1,6581 1.658
2016-10-14 CSBR ACKERMAN JOEL 300 1,6500 300 1,6500 495
2016-10-13 CSBR ACKERMAN JOEL 500 1,6844 500 1,6844 842
2016-10-13 CSBR ACKERMAN JOEL 500 1,6890 500 1,6890 844
2016-10-13 CSBR ACKERMAN JOEL 1.000 1,6700 1.000 1,6700 1.670
2016-10-13 CSBR ACKERMAN JOEL 1.000 1,6700 1.000 1,6700 1.670
2016-10-13 CSBR ACKERMAN JOEL 1.000 1,6766 1.000 1,6766 1.677
2016-10-13 CSBR ACKERMAN JOEL 1.000 1,6790 1.000 1,6790 1.679
2016-10-13 CSBR ACKERMAN JOEL 1.000 1,6700 1.000 1,6700 1.670
2016-10-07 CSBR ACKERMAN JOEL 5.000 1,6400 5.000 1,6400 8.200
2016-10-06 CSBR ACKERMAN JOEL 1.000 1,6108 1.000 1,6108 1.611
2016-10-06 CSBR ACKERMAN JOEL 702 1,6200 702 1,6200 1.137
2016-10-06 CSBR ACKERMAN JOEL 1.500 1,6143 1.500 1,6143 2.421
2016-09-23 CSBR ACKERMAN JOEL 33 1,6500 33 1,6500 54
2016-09-21 CSBR ACKERMAN JOEL 1.000 1,7000 1.000 1,7000 1.700
2016-09-21 CSBR ACKERMAN JOEL 1.000 1,7287 1.000 1,7287 1.729
2016-09-20 CSBR ACKERMAN JOEL 1.000 1,6274 1.000 1,6274 1.627
2016-09-20 CSBR ACKERMAN JOEL 1.000 1,6399 1.000 1,6399 1.640
2016-09-20 CSBR ACKERMAN JOEL 1.000 1,6277 1.000 1,6277 1.628
2015-03-11 CSBR ACKERMAN JOEL 2.710.526 0,0000 225.877 0,0000 0
2013-01-28 CSBR ACKERMAN JOEL 500.000 0,5000 41.667 6,0000 250.000

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

CSBR / Champions Oncology, Inc. Insider Trades
Insidersalg CSBR / Champions Oncology, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i CSBR / Champions Oncology, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2018-10-01 CSBR ACKERMAN JOEL 22.535 17,0200 22.535 17,0200 383.546 333 5.4 -261.856 -68,27

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

CSBR / Champions Oncology, Inc. Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Joel Ackerman som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2025-03-18 2025-03-15 4 DVA DAVITA INC.
Common Stock
F - Taxes -3.331 141.640 -2,30 143,45 -477.832 20.318.258
2025-03-18 2025-03-15 4 DVA DAVITA INC.
Common Stock
F - Taxes -3.093 144.971 -2,09 143,45 -443.691 20.796.090
2025-03-18 2025-03-15 4 DVA DAVITA INC.
Common Stock
A - Award 5.995 148.064 4,22
2025-03-14 2025-03-12 4 DVA DAVITA INC.
Common Stock
A - Award 7.221 142.069 5,35
2025-03-14 2025-03-12 4 DVA DAVITA INC.
Common Stock
A - Award 7.394 134.848 5,80
2024-11-01 2024-10-31 4 CSBR CHAMPIONS ONCOLOGY, INC.
Common Stock
M - Exercise 16.667 962.134 1,76 5,43 90.502 5.224.388
2024-11-01 2024-10-31 4 CSBR CHAMPIONS ONCOLOGY, INC.
Common Stock
M - Exercise 88.470 945.467 10,32 2,10 185.787 1.985.481
2024-09-17 2024-09-16 4 DVA DAVITA INC.
Common Stock
F - Taxes -21.602 127.454 -14,49 163,56 -3.533.223 20.846.376
2024-09-17 2024-09-16 4 DVA DAVITA INC.
Common Stock
D - Sale to Issuer -36.684 149.056 -19,75 163,56 -6.000.035 24.379.599
2024-09-17 2024-09-16 4 DVA DAVITA INC.
Common Stock
M - Exercise 78.999 185.740 74,01 75,95 5.999.974 14.106.953
2024-08-29 2024-08-28 4 DVA DAVITA INC.
Common Stock
S - Sale -4.740 106.741 -4,25 155,02 -734.785 16.546.766
2024-08-29 2024-08-27 4 DVA DAVITA INC.
Common Stock
S - Sale -64.029 111.481 -36,48 155,06 -9.928.586 17.286.679
2024-03-18 2024-03-15 4 DVA DAVITA INC.
Common Stock
F - Taxes -8.064 175.510 -4,39 136,00 -1.096.704 23.869.360
2024-03-18 2024-03-15 4 DVA DAVITA INC.
Common Stock
A - Award 10.977 183.574 6,36
2024-03-18 2024-03-14 4 DVA DAVITA INC.
Common Stock
A - Award 1.445 172.597 0,84
2024-03-18 2024-03-14 4 DVA DAVITA INC.
Common Stock
A - Award 14.349 171.152 9,15
2024-03-08 2024-03-06 4 DVA DAVITA INC.
Common Stock
F - Taxes -17.149 156.803 -9,86 134,65 -2.309.113 21.113.524
2024-03-08 2024-03-06 4 DVA DAVITA INC.
Common Stock
D - Sale to Issuer -21.408 173.952 -10,96 134,65 -2.882.587 23.422.637
2024-03-08 2024-03-06 4 DVA DAVITA INC.
Common Stock
M - Exercise 55.000 195.360 39,18 52,41 2.882.550 10.238.818
2024-02-23 2024-02-21 4 DVA DAVITA INC.
Common Stock
F - Taxes -14.930 140.360 -9,61 123,00 -1.836.390 17.264.280
2024-02-23 2024-02-21 4 DVA DAVITA INC.
Common Stock
D - Sale to Issuer -23.436 155.290 -13,11 123,00 -2.882.628 19.100.670
2024-02-23 2024-02-21 4 DVA DAVITA INC.
Common Stock
M - Exercise 55.000 178.726 44,45 52,41 2.882.550 9.367.030
2024-01-05 2023-10-17 4 CSBR CHAMPIONS ONCOLOGY, INC.
Common Stock
M - Exercise 114.552 856.997 15,43 2,10 240.559 1.799.694
2023-05-17 2023-05-15 4 DVA DAVITA INC.
Common Stock
F - Taxes -12.861 123.726 -9,42 96,86 -1.245.716 11.984.100
2023-05-17 2023-05-15 4 DVA DAVITA INC.
Common Stock
F - Taxes -7.625 136.587 -5,29 96,86 -738.558 13.229.817
2023-05-12 2023-05-10 4 DVA DAVITA INC.
Common Stock
F - Taxes -9.826 144.212 -6,38 100,72 -989.675 14.525.033
2023-05-12 2023-05-10 4 DVA DAVITA INC.
Common Stock
D - Sale to Issuer -37.059 154.038 -19,39 100,72 -3.732.582 15.514.707
2023-05-12 2023-05-10 4 DVA DAVITA INC.
Common Stock
M - Exercise 56.306 191.097 41,77 66,29 3.732.525 12.667.820
2023-04-06 2023-04-04 4 DVA DAVITA INC.
Common Stock
A - Award 2.790 134.791 2,11
2023-03-17 2023-03-15 4 DVA DAVITA INC.
Common Stock
F - Taxes -709 132.001 -0,53 76,04 -53.912 10.037.356
2023-03-17 2023-03-15 4 DVA DAVITA INC.
Common Stock
F - Taxes -4.260 132.710 -3,11 76,04 -323.930 10.091.268
2023-03-17 2023-03-15 4 DVA DAVITA INC.
Common Stock
A - Award 23.672 136.970 20,89
2023-03-13 2023-03-09 4 DVA DAVITA INC.
Common Stock
A - Award 1.387 113.298 1,24
2023-02-27 2023-02-23 4 DVA DAVITA INC.
Common Stock
A - Award 8.343 111.911 8,06
2023-02-27 2023-02-23 4 DVA DAVITA INC.
Common Stock
A - Award 22.400 103.568 27,60
2022-10-20 2022-10-19 4 CSBR CHAMPIONS ONCOLOGY, INC.
Common Stock
M - Exercise 16.667 1.460.595 1,15 3,21 53.501 4.688.510
2022-05-17 2022-05-15 4 DVA DAVITA INC.
Common Stock
F - Taxes -7.624 81.168 -8,59 100,05 -762.781 8.120.858
2022-05-17 2022-05-15 4 DVA DAVITA INC.
Common Stock
F - Taxes -14.082 88.792 -13,69 100,05 -1.408.904 8.883.640
2022-05-17 2022-05-15 4 DVA DAVITA INC.
Common Stock
F - Taxes -2.875 102.874 -2,72 100,05 -287.644 10.292.544
2022-05-17 2022-05-15 4 DVA DAVITA INC.
Common Stock
F - Taxes -9.414 105.749 -8,17 100,05 -941.871 10.580.187
2022-04-21 2022-04-19 4 DVA DAVITA INC.
Common Stock
A - Award 28.385 115.163 32,71
2022-04-21 2022-04-19 4 DVA DAVITA INC.
Common Stock
A - Award 18.438 86.778 26,98
2022-03-17 2022-03-15 4 DVA DAVITA INC.
Common Stock
A - Award 43.388 43.388
2021-11-09 2021-11-05 4 CSBR CHAMPIONS ONCOLOGY, INC.
Option to purchase Common Stock
A - Award 18.564 18.564 10,10 187.496 187.496
2021-08-11 2021-08-09 4 DVA DAVITA INC.
Stock Appreciation Rights
M - Exercise -145.159 0 -100,00
2021-08-11 2021-08-09 4 DVA DAVITA INC.
Common Stock
F - Taxes -37.226 68.340 -35,26 133,17 -4.957.386 9.100.838
2021-08-11 2021-08-09 4 DVA DAVITA INC.
Common Stock
D - Sale to Issuer -75.093 105.566 -41,57 133,17 -10.000.135 14.058.224
2021-08-11 2021-08-09 4 DVA DAVITA INC.
Common Stock
M - Exercise 145.159 180.659 408,90 68,89 10.000.004 12.445.599
2021-08-06 2021-08-05 4 DVA DAVITA INC.
Common Stock
S - Sale -37.760 35.500 -51,54 131,36 -4.960.146 4.663.273
2021-05-18 2021-05-15 4 DVA DAVITA INC.
Common Stock
F - Taxes -8.272 73.260 -10,15 125,41 -1.037.392 9.187.537
2021-05-18 2021-05-15 4 DVA DAVITA INC.
Common Stock
F - Taxes -1.419 81.532 -1,71 125,41 -177.957 10.224.928
2021-05-18 2021-05-15 4 DVA DAVITA INC.
Common Stock
F - Taxes -2.756 82.951 -3,22 125,41 -345.630 10.402.885
2021-05-18 2021-05-15 4 DVA DAVITA INC.
Common Stock
F - Taxes -11.180 85.707 -11,54 125,41 -1.402.084 10.748.515
2021-05-18 2021-05-15 4 DVA DAVITA INC.
Common Stock
F - Taxes -712 96.887 -0,73 125,41 -89.292 12.150.599
2021-04-21 2021-04-19 4 DVA DAVITA INC.
Common Stock
A - Award 2.899 97.599 3,06
2021-04-21 2021-04-19 4 DVA DAVITA INC.
Common Stock
A - Award 1.456 94.700 1,56
2021-03-17 2021-03-15 4 DVA DAVITA INC.
Stock Appreciation Rights
A - Award 44.065 44.065
2021-03-01 2021-02-25 4 DVA DAVITA INC.
Common Stock
A - Award 16.894 93.244 22,13
2021-03-01 2021-02-25 4 DVA DAVITA INC.
Common Stock
A - Award 22.832 76.350 42,66
2020-12-21 2020-12-19 4 DVA DAVITA INC.
Common Stock
F - Taxes -4.890 53.518 -8,37 115,36 -564.110 6.173.836
2020-12-10 2020-12-08 4 CSBR CHAMPIONS ONCOLOGY, INC.
Option to purchase Common Stock
A - Award 16.667 16.667 11,96 199.337 199.337
2020-11-03 2020-03-03 4 CSBR CHAMPIONS ONCOLOGY, INC.
Warrant to purchase shares of Common Stock
M - Exercise -2.708 0 -100,00 4,80 -12.998
2020-11-03 2020-03-03 4 CSBR CHAMPIONS ONCOLOGY, INC.
Warrant to purchase shares of Common Stock
M - Exercise -124.232 0 -100,00 5,76 -715.576
2020-11-03 2020-03-03 4 CSBR CHAMPIONS ONCOLOGY, INC.
Common Stock
M - Exercise 2.708 1.443.928 0,19 4,80 12.998 6.930.854
2020-11-03 2020-03-03 4 CSBR CHAMPIONS ONCOLOGY, INC.
Common Stock
M - Exercise 124.232 1.441.220 9,43 5,76 715.576 8.301.427
2020-05-19 2020-05-15 4 DVA DAVITA INC.
Common Stock
F - Taxes -425 58.408 -0,72 79,25 -33.681 4.628.834
2020-05-19 2020-05-15 4 DVA DAVITA INC.
Common Stock
A - Award 1.116 58.833 1,93
2020-03-17 2020-03-15 4 DVA DAVITA INC.
Stock Appreciation Rights
A - Award 78.999 78.999
2019-12-04 2019-12-02 4 CSBR CHAMPIONS ONCOLOGY, INC.
Option to purchase Common Stock
M - Exercise -1.521 0 -100,00 2,10 -3.194
2019-12-04 2019-12-02 4 CSBR CHAMPIONS ONCOLOGY, INC.
Option to purchase Common Stock
M - Exercise -201.590 0 -100,00 2,10 -423.339
2019-12-04 2019-12-02 4 CSBR CHAMPIONS ONCOLOGY, INC.
Common Stock
M - Exercise 1.521 1.316.988 0,12 2,10 3.194 2.765.675
2019-12-04 2019-12-02 4 CSBR CHAMPIONS ONCOLOGY, INC.
Common Stock
M - Exercise 201.590 1.315.467 18,10 2,10 423.339 2.762.481
2019-11-06 2019-11-04 4 CSBR CHAMPIONS ONCOLOGY, INC.
Option to purchase Common Stock
A - Award 16.667 16.667 5,43 90.502 90.502
2019-06-21 2019-06-20 4 DVA DAVITA INC.
Stock Appreciation Rights
A - Award 110.000 110.000
2019-06-21 2019-06-19 4 DVA DAVITA INC.
Common Stock
F - Taxes -6.014 57.717 -9,44
2019-06-21 2019-06-19 4 DVA DAVITA INC.
Common Stock
A - Award 22.601 63.731 54,95
2019-05-17 2019-05-15 4 DVA DAVITA INC.
Common Stock
A - Award 29.869 41.130 265,24
2019-01-04 2019-01-02 4 CSBR CHAMPIONS ONCOLOGY, INC.
Warrant to purchase shares of Common Stock
M - Exercise 4.167 1.494.956 0,28
2019-01-04 2019-01-02 4 CSBR CHAMPIONS ONCOLOGY, INC.
Common Stock
M - Exercise 4.167 1.113.877 0,38 4,80 20.002 5.346.610
2018-11-05 2018-11-01 4 CSBR CHAMPIONS ONCOLOGY, INC.
Option to purchase Common Stock
A - Award 16.667 16.667 12,73 212.171 212.171
2018-10-12 2018-10-12 4 CSBR CHAMPIONS ONCOLOGY, INC.
Option to purchase Common Stock
M - Exercise -100.000 0 -100,00
2018-10-12 2018-10-12 4 CSBR CHAMPIONS ONCOLOGY, INC.
Common Stock
F - Taxes -12.021 1.109.710 -1,07 17,47 -210.007 19.386.634
2018-10-12 2018-10-12 4 CSBR CHAMPIONS ONCOLOGY, INC.
Common Stock
M - Exercise 100.000 1.121.731 9,79 2,10 210.000 2.355.635
2018-10-03 2018-10-01 4 CSBR CHAMPIONS ONCOLOGY, INC.
Common Stock
S - Sale -22.535 1.021.731 -2,16 17,02 -383.546 17.389.862
2018-07-02 2018-07-02 4 KND KINDRED HEALTHCARE, INC
Common Stock
D - Sale to Issuer -75.167 0 -100,00 9,00 -676.503
2018-05-17 2018-05-15 4 DVA DAVITA INC.
Stock Appreciation Rights
A - Award 56.306 56.306
2018-05-17 2018-05-15 4 DVA DAVITA INC.
Restricted Stock Units
A - Award 11.261 11.261
2017-11-13 2017-11-08 4 CSBR CHAMPIONS ONCOLOGY, INC.
Option to purchase Common Stock
A - Award 16.667 16.667 3,21 53.501 53.501
2017-05-25 2017-05-24 4 KND KINDRED HEALTHCARE, INC
Common Stock
A - Award 14.852 75.167 24,62
2017-02-23 2017-02-21 4 DVA DAVITA INC.
Stock Appreciation Rights
A - Award 145.159 145.159
2017-02-23 3 DVA DAVITA INC.
No securities are beneficially owned.
0
2017-02-23 2017-02-21 4/A DVA DAVITA INC.
Stock Appreciation Rights
A - Award 145.159 145.159
2017-02-23 3/A DVA DAVITA INC.
No securities are beneficially owned.
0
2016-11-01 2016-10-28 4 CSBR CHAMPIONS ONCOLOGY, INC.
Option to purchase Common Stock
A - Award 279.177 279.177
2016-10-20 2016-10-18 4 CSBR CHAMPIONS ONCOLOGY, INC.
Common Stock
P - Purchase 418 1.044.266 0,04 1,70 711 1.775.252
2016-10-20 2016-10-18 4 CSBR CHAMPIONS ONCOLOGY, INC.
Common Stock
P - Purchase 381 1.043.848 0,04 1,69 644 1.764.103
2016-10-20 2016-10-18 4 CSBR CHAMPIONS ONCOLOGY, INC.
Common Stock
P - Purchase 201 1.043.467 0,02 1,69 340 1.767.633
2016-10-20 2016-10-18 4 CSBR CHAMPIONS ONCOLOGY, INC.
Common Stock
P - Purchase 1.000 1.043.266 0,10 1,70 1.698 1.771.153
2016-10-14 2016-10-14 4 CSBR CHAMPIONS ONCOLOGY, INC.
Common Stock
P - Purchase 300 1.042.266 0,03 1,65 495 1.719.739
2016-10-14 2016-10-14 4 CSBR CHAMPIONS ONCOLOGY, INC.
Common Stock
P - Purchase 1.000 1.041.966 0,10 1,66 1.658 1.727.684
2016-10-14 2016-10-13 4 CSBR CHAMPIONS ONCOLOGY, INC.
Common Stock
P - Purchase 1.000 1.040.966 0,10 1,67 1.670 1.738.413
2016-10-14 2016-10-13 4 CSBR CHAMPIONS ONCOLOGY, INC.
Common Stock
P - Purchase 1.000 1.040.966 0,10 1,67 1.670 1.738.413
2016-10-14 2016-10-13 4 CSBR CHAMPIONS ONCOLOGY, INC.
Common Stock
P - Purchase 1.000 1.040.966 0,10 1,67 1.670 1.738.413
2016-10-14 2016-10-13 4 CSBR CHAMPIONS ONCOLOGY, INC.
Common Stock
P - Purchase 1.000 1.039.966 0,10 1,68 1.679 1.746.103
2016-10-14 2016-10-13 4 CSBR CHAMPIONS ONCOLOGY, INC.
Common Stock
P - Purchase 1.000 1.038.966 0,10 1,68 1.677 1.741.930
2016-10-14 2016-10-13 4 CSBR CHAMPIONS ONCOLOGY, INC.
Common Stock
P - Purchase 500 1.035.966 0,05 1,69 844 1.749.747
2016-10-14 2016-10-13 4 CSBR CHAMPIONS ONCOLOGY, INC.
Common Stock
P - Purchase 500 1.035.466 0,05 1,68 842 1.744.139
2016-10-07 2016-10-07 4 CSBR CHAMPIONS ONCOLOGY, INC.
Common Stock
P - Purchase 5.000 1.034.966 0,49 1,64 8.200 1.697.344
2016-10-07 2016-10-06 4 CSBR CHAMPIONS ONCOLOGY, INC.
Common Stock
P - Purchase 1.500 1.029.966 0,15 1,61 2.421 1.662.674
2016-10-07 2016-10-06 4 CSBR CHAMPIONS ONCOLOGY, INC.
Common Stock
P - Purchase 702 1.028.466 0,07 1,62 1.137 1.666.115
2016-10-07 2016-10-06 4 CSBR CHAMPIONS ONCOLOGY, INC.
Common Stock
P - Purchase 1.000 1.027.764 0,10 1,61 1.611 1.655.522
2016-09-26 2016-09-23 4 CSBR CHAMPIONS ONCOLOGY, INC.
Common Stock
P - Purchase 33 1.026.764 0,00 1,65 54 1.694.161
2016-09-21 2016-09-21 4 CSBR CHAMPIONS ONCOLOGY, INC.
Common Stock
P - Purchase 1.000 1.026.731 0,10 1,73 1.729 1.774.910
2016-09-21 2016-09-21 4 CSBR CHAMPIONS ONCOLOGY, INC.
Common Stock
P - Purchase 1.000 1.025.731 0,10 1,70 1.700 1.743.743
2016-09-21 2016-09-20 4 CSBR CHAMPIONS ONCOLOGY, INC.
Common Stock
P - Purchase 1.000 1.024.731 0,10 1,63 1.628 1.667.955
2016-09-21 2016-09-20 4 CSBR CHAMPIONS ONCOLOGY, INC.
Common Stock
P - Purchase 1.000 1.023.731 0,10 1,64 1.640 1.678.816
2016-09-21 2016-09-20 4 CSBR CHAMPIONS ONCOLOGY, INC.
Common Stock
P - Purchase 1.000 1.022.731 0,10 1,63 1.627 1.664.392
2016-09-14 2016-07-21 4 CSBR CHAMPIONS ONCOLOGY, INC.
Option to purchase Common Stock
D - Sale to Issuer -100.765 0 -100,00
2016-09-14 2016-07-21 4 CSBR CHAMPIONS ONCOLOGY, INC.
Option to purchase Common Stock
D - Sale to Issuer -96.283 0 -100,00
2016-09-14 2016-07-21 4 CSBR CHAMPIONS ONCOLOGY, INC.
Option to purchase Common Stock
D - Sale to Issuer -16.101 0 -100,00
2016-09-14 2016-07-21 4 CSBR CHAMPIONS ONCOLOGY, INC.
Option to purchase Common Stock
D - Sale to Issuer -112.331 0 -100,00
2016-09-14 2016-07-21 4 CSBR CHAMPIONS ONCOLOGY, INC.
Option to purchase Common Stock
D - Sale to Issuer -112.331 0 -100,00
2016-09-14 2016-07-21 4 CSBR CHAMPIONS ONCOLOGY, INC.
Option to purchase Common Stock
D - Sale to Issuer -182.580 0 -100,00
2016-09-14 2016-07-21 4 CSBR CHAMPIONS ONCOLOGY, INC.
Option to purchase Common Stock
D - Sale to Issuer -182.580 0 -100,00
2016-09-14 2016-07-21 4 CSBR CHAMPIONS ONCOLOGY, INC.
Option to purchase Common Stock
A - Award 94.405 94.405
2016-09-14 2016-07-21 4 CSBR CHAMPIONS ONCOLOGY, INC.
Option to purchase Common Stock
A - Award 88.470 88.470
2016-09-14 2016-07-21 4 CSBR CHAMPIONS ONCOLOGY, INC.
Option to purchase Common Stock
A - Award 14.552 14.552
2016-09-14 2016-07-21 4 CSBR CHAMPIONS ONCOLOGY, INC.
Option to purchase Common Stock
A - Award 101.521 101.521
2016-09-14 2016-07-21 4 CSBR CHAMPIONS ONCOLOGY, INC.
Option to purchase Common Stock
A - Award 101.521 101.521
2016-09-14 2016-07-21 4 CSBR CHAMPIONS ONCOLOGY, INC.
Option to purchase Common Stock
A - Award 150.795 150.795
2016-09-14 2016-07-21 4 CSBR CHAMPIONS ONCOLOGY, INC.
Option to purchase Common Stock
A - Award 150.795 150.795
2016-05-26 2016-05-25 4 KND KINDRED HEALTHCARE, INC
Common Stock
A - Award 12.356 60.315 25,76
2015-11-23 2015-11-19 4 CSBR CHAMPIONS ONCOLOGY, INC.
Option to purchase Common Stock
A - Award 100.765 100.765
2015-03-27 2015-03-26 4 KND KINDRED HEALTHCARE, INC
Common Stock
A - Award 6.416 47.959 15,44
2015-03-23 2015-03-16 4 CSBR CHAMPIONS ONCOLOGY, INC.
Option to purchase Common Stock
A - Award 1.155.400 1.155.400
2015-03-23 2015-03-16 4 CSBR CHAMPIONS ONCOLOGY, INC.
Option to purchase Common Stock
A - Award 193.210 193.210
2015-03-23 2015-03-16 4 CSBR CHAMPIONS ONCOLOGY, INC.
Option to purchase Common Stock
A - Award 1.347.977 1.347.977
2015-03-23 2015-03-16 4 CSBR CHAMPIONS ONCOLOGY, INC.
Option to purchase Common Stock
A - Award 1.347.977 1.347.977
2015-03-23 2015-03-16 4 CSBR CHAMPIONS ONCOLOGY, INC.
Option to purchase Common Stock
A - Award 2.190.959 2.190.959
2015-03-23 2015-03-16 4 CSBR CHAMPIONS ONCOLOGY, INC.
Option to purchase Common Stock
A - Award 2.190.958 2.190.958
2015-03-17 2015-03-11 4 CSBR CHAMPIONS ONCOLOGY, INC.
Warrant to purchase shares of Common Stock
A - Award 1.490.789 1.490.789
2015-03-17 2015-03-11 4 CSBR CHAMPIONS ONCOLOGY, INC.
Common Stock
J - Other 70.826 3.643.000 1,98
2015-03-17 2015-03-11 4 CSBR CHAMPIONS ONCOLOGY, INC.
Common Stock
P - Purchase 2.710.526 3.572.174 314,57
2015-01-13 2014-12-01 4 CSBR CHAMPIONS ONCOLOGY, INC.
Convertible Promissory Note
A - Award 1.000.000,00
2014-03-27 2014-03-26 4 KND KINDRED HEALTHCARE, INC
Common Stock
A - Award 6.610 41.543 18,92
2013-11-07 2013-11-05 4 CSBR CHAMPIONS ONCOLOGY, INC.
Stock Options
A - Award 215.000 215.000
2013-11-07 2013-11-05 4 CSBR CHAMPIONS ONCOLOGY, INC.
Stock Options
A - Award 1.500.000 1.500.000
2013-11-07 2013-11-05 4 CSBR CHAMPIONS ONCOLOGY, INC.
Stock Options
A - Award 1.500.000 1.500.000
2013-05-09 2013-05-07 4 CVH COVENTRY HEALTH CARE INC
Restricted Stock Units
D - Sale to Issuer -49.698 0 -100,00
2013-05-09 2013-05-07 4 CVH COVENTRY HEALTH CARE INC
Restricted Stock Units
A - Award 647 49.698 1,32
2013-05-09 2013-05-07 4 CVH COVENTRY HEALTH CARE INC
Non-Qualified Stock Option (right to buy)
D - Sale to Issuer -28.230 0 -100,00
2013-05-09 2013-05-07 4 CVH COVENTRY HEALTH CARE INC
Common Stock Restricted
D - Sale to Issuer -4.500 0 -100,00
2013-05-09 2013-05-07 4 CVH COVENTRY HEALTH CARE INC
Common Stock
D - Sale to Issuer -1.636 0 -100,00
2013-03-26 2013-03-25 4 KND KINDRED HEALTHCARE, INC
Common Stock
A - Award 11.737 34.933 50,60
2013-01-30 2013-01-28 4 CSBR CHAMPIONS ONCOLOGY, INC.
Warrant to purchase shares of Common Stock
A - Award 50.000 50.000
2013-01-30 2013-01-28 4 CSBR CHAMPIONS ONCOLOGY, INC.
Common Stock
J - Other 28.315 861.648 3,40
2013-01-30 2013-01-28 4 CSBR CHAMPIONS ONCOLOGY, INC.
Common Stock
P - Purchase 500.000 833.333 150,00 0,50 250.000 416.666
2013-01-03 2013-01-01 4 CVH COVENTRY HEALTH CARE INC
Restricted Stock Units
A - Award 5.018 49.051 11,40
2012-12-04 2012-12-03 4 CVH COVENTRY HEALTH CARE INC
Common Stock
S - Sale -3.291 0 -100,00 43,82 -144.212
2012-03-28 2012-03-26 4 KND KINDRED HEALTHCARE, INC
Common Stock
A - Award 10.650 23.196 84,89
2012-01-04 2012-01-01 4 CVH COVENTRY HEALTH CARE INC
Restricted Stock Units
A - Award 7.408 81.690 9,97
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)